Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
REPRO-MED Systems (KRMD) Stock Price & Analysis
268 Followers
KRMD Stock Chart & Stats
Day’s Range$2.24 - $2.39
52-Week Range― - ―
Previous Close$2.26
Volume53.74K
Average Volume (3M)N/A
Market Cap
$103.43M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 06, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.50Price Target Upside55.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
REPRO-MED Systems News
PremiumPre-Earnings
Is KRMD a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ1 revenue of $8.2M was above expectations, showcasing a strong start to the year.
Market ExpansionInternational core revenue grew significantly, indicating successful expansion efforts.
Product InnovationManagement plans to submit two new 510(k) applications by year-end, indicating ongoing product innovation and potential for market expansion.
Bears Say
Competitive PressuresPotential for competitive pressures to expand, posing risks to market share and profitability.
Margin PressureKORU Medical Systems may see reduced profitability due to increasing inflationary, material, and labor costs despite global expansion.
Revenue DeclineNovel Therapies revenue was down, suggesting challenges in that business segment.
---
Ownership Overview
28.53% Insiders
6.20% Mutual Funds
8.71% Other Institutional Investors
56.55% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
Currently, no data Available
What is REPRO-MED Systems’s market cap?
Currently, no data Available
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is Aug 06, 2024 which is in 89 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on May 01, 2024. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.038 by -$0.002.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -$0.04.
How many shares outstanding does REPRO-MED Systems have?
Currently, no data Available
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.038. Following the earnings report the stock price went up 5.778%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Among the largest hedge funds holding REPRO-MED Systems’s share is Horton Capital Management, LLC. It holds REPRO-MED Systems’s shares valued at 26M.
---
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.50 (55.56% Upside)
$3.50 (55.56% Upside)
Blogger Sentiment
Neutral
KRMD Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.64%
12-Months-Change
Fundamentals
Return on Equity
-54.24%
Trailing 12-Months
Asset Growth
-28.11%
Trailing 12-Months
Company Description
REPRO-MED Systems
Repro-Med Systems, Inc.engages in the design, manufacture, and market of proprietary medical devices. It products include FREEDOM60, a syringe infusion pump, which is designed for ambulatory medication infusions; HIgH-Flo, is designed for self-administration of medicine under the skin; and RES-Q-VAC, is a portable and hand-operated suction device that removes fluids from a patients airway. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.
---
KRMD Company Deck
---
KRMD Earnings Call
Q1 2024
0:00 / 0:00
---
KRMD Stock 12 Month Forecast
Average Price Target
$3.50
▲(55.56% Upside)
Technical Analysis
Best Analysts Covering KRMD
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-0.72%
assigned a buy rating 8 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -0.72% per trade.
---